IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vistagen Therapeutics Inc (VTGNUSD)

Q1 2024 vs Q2 2024

Comparing institutional holders between quarters

Quarters

Q2 2024Q1 2024Q4 2023Q2 2023Q1 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
TCG Crossover Management, LLC
UNCHANGED
Shares2,676,580 from 2,676,580
Change0 (0%)
Value$9.3M (-$4.8M)
Filed 2024-08-14
Status
TCG Crossover Management, LLC
UNCHANGED2,676,5802,676,58000%$14.1M$9.3M-$4.8M2024-08-14
Showing 1 of 1 institutions